Before you sell to, join or invest in Biostate AI, Inc
MentionFox check on Biostate AI, Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/biostate-ai-inc-form-d-25000001
Check Biostate AI, Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Biostate AI, Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Biostate AI, Inc filed a Form D with the Securities and Exchange Commission on 2025-05-12.
Biostate AI, Inc filed a Form D notice of an exempt securities offering with the SEC on May 12, 2025. The filing reports $4.18M sold. Its industry group is Biotechnology. It names David Zhang (Executive Officer, Director), Ashwin Gopinath (Executive Officer, Director), Eva Miao (Executive Officer) (SEC Form D, May 12, 2025).
Is this your company?
Sell to companies like Biostate AI, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Biostate AI, Inc.
Free to see. No signup.
More on the people and the money behind Biostate AI, Inc, from the filings we hold.
Biotechnology raises by companies based in Texas, filed in May 2025, largest first.
Get an email when Biostate AI, Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Biostate AI, Inc raises, hires or launches. No email unless you switch it on.
Watch Biostate AI, Inc →Get the full cited report on Biostate AI, Inc
What the filing shows about Biostate AI, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Biostate AI, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Biostate AI, Inc's address as 7505 Fannin St., Suite 610, Houston, TX 77054.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Biostate AI, Inc is a registered filer with the SEC (CIK 1990762) and has filed since 2023-08-23. 2 filings are on record, the latest on 2025-05-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Biostate AI, Inc's Form D of 2025-05-12 names David Zhang, Ashwin Gopinath and Eva Miao as its officers, directors or promoters.
Its new offerings report $5.18M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
David Zhang is named as Executive Officer and Director on the Form D that Biostate AI, Inc filed with the SEC on 12 May 2025, one of 3 people that filing names.
Ashwin Gopinath is named as Executive Officer and Director on the Form D that Biostate AI, Inc filed with the SEC on 12 May 2025, one of 3 people that filing names.
Eva Miao is named as Executive Officer on the Form D that Biostate AI, Inc filed with the SEC on 12 May 2025, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2025-05-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Biostate AI, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Biostate AI, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biostate AI, Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Biostate AI, IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Biostate AI, Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Biostate AI, Inc. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/biostate-ai-inc-form-d-25000001